Onego Bio Receives FDA “No Questions” Letter on GRAS Status of Bioalbumen®

Contributed by: Business Wire

Logo

Tags

Food Tech

Retail

FDA

Health

Technology

Food/Beverage

Onego Bio

More Like This

Onego Bio Submits Formal GRAS Notification to FDA for Bioalbumen®

21st.BIO obtains self-affirmed GRAS status for its precision fermented beta-lactoglobulin: 21st.BIO customers can now enter the U.S. market with their own production using 21st.BIO technology

21st.BIO launches precision fermentation program for bovine alpha-lactalbumin

/DISREGARD RELEASE: Angel Yeast/

PR Newswire associated0

Glac Biotech Secures U.S. Food and Drug Administration GRAS Approval for Probiotic Strain CP-9

GlobeNewswire associated0

Sweden’s Millow Commissions World‑First Oat‑and‑Mycelium Factory to Craft Beef‑Like, Clean‑Label Protein

Today is a special day for Danish FERM FOOD ApS, which has received the EU Commission's authorisation to use fermented rapeseed cake as a food ingredient (Left: Founder and CEO Jens Legarth, right: Head of Development Søren Lange).

EU Authorisation Allows for Fermented Rapeseed Cake to Be Applied in Food

PR Newswire associated0

Allozymes and Adisseo Partner on Next-Gen Animal Feed Production Using Rapid Microfluidics Technology